2860 Forbs Ave
About CMIC Inc
CMIC Inc. located in Chicago, Illinois is a global CRO with over 30 years’ experience, the laboratory offers bioanalysis for non-clinical and clinical projects, both GLP and non-GLP within a state-of-the-art facility that has the capacity to accommodate quick turnaround for high-volume projects. CMIC’s skilled researchers provide deep expertise in small and large molecule bioanalysis, biomarker services and oligonucleotide bioanalysis expertise. Purpose built in 2010, CMIC Inc.’s contract bioanalytical and biomarker laboratory is located just 25 minutes West of Chicago O’Hare International and is one of four global contract laboratories in the CMIC Holdings group.
11 articles about CMIC Inc
Speakers from Sanofi and CMIC discussed their respective experiences with DCT in Europe and Japan during Informa Connect’s Decentralized Clinical Trials hybrid meeting, held June 6-8.
CMIC Co., Ltd. has launched services using SUSMED, Inc.’s trial management system covering subject registration, software assignment and distribution for digital therapeutics.
Aprecia and CMIC, a Leading CDMO in Japan, have established an agreement to bring 3DP pharmaceutical products to Japan
Leading Japanese pharma value creator to lead Aprecia's Business Development in Japan
Aesica and CMIC Co., Ltd. Sign Collaborative Agreement for International Business Expansion Across European, Japanese and U.S. Markets
Dyax Corp., CMIC Co., Ltd. to Develop, Market Angioedema Drug; Dyax to Receive $4 Million Upfront and Eligible for $102 Million More in Milestone Payments
Leading Japanese CRO CMIC Co., Ltd. Attains Highest Accreditation in Medidata Solutions, Inc.' ASPire to Win Partner Program
PHT Corporation, CMIC Co., Ltd. Establish a Support Network for Electronic Clinical Trial Data Capture Systems
Leading Japanese CRO CMIC Co., Ltd. Partners with Medidata Solutions, Inc. Through ASPire to Win Program
Accium BioSciences, Inc. And CMIC Co., Ltd. Announce Strategic Alliance To Provide Exploratory IND And Low-Radiation PK/ADME Services To The Japanese Pharmaceutical Industry